GNTA
Price
$4.00
Change
-$0.30 (-6.98%)
Updated
Jun 6 closing price
Capitalization
73.19M
SRRK
Price
$34.23
Change
-$0.02 (-0.06%)
Updated
Jun 6 closing price
Capitalization
3.25B
60 days until earnings call
Interact to see
Advertisement

GNTA vs SRRK

Header iconGNTA vs SRRK Comparison
Open Charts GNTA vs SRRKBanner chart's image
Genenta Science SpA
Price$4.00
Change-$0.30 (-6.98%)
Volume$2.71K
Capitalization73.19M
Scholar Rock Holding
Price$34.23
Change-$0.02 (-0.06%)
Volume$1.83M
Capitalization3.25B
GNTA vs SRRK Comparison Chart
Loading...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNTA vs. SRRK commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNTA is a Hold and SRRK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (GNTA: $4.00 vs. SRRK: $34.23)
Brand notoriety: GNTA and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNTA: 46% vs. SRRK: 145%
Market capitalization -- GNTA: $73.19M vs. SRRK: $3.25B
GNTA [@Biotechnology] is valued at $73.19M. SRRK’s [@Biotechnology] market capitalization is $3.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNTA’s FA Score shows that 0 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • GNTA’s FA Score: 0 green, 5 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, GNTA is a better buy in the long-term than SRRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRRK’s TA Score shows that 5 TA indicator(s) are bullish.

  • SRRK’s TA Score: 5 bullish, 4 bearish.

Price Growth

GNTA (@Biotechnology) experienced а -11.07% price change this week, while SRRK (@Biotechnology) price change was +17.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

GNTA is expected to report earnings on Mar 28, 2025.

SRRK is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($3.25B) has a higher market cap than GNTA($73.2M). GNTA YTD gains are higher at: -8.002 vs. SRRK (-20.801).
GNTASRRKGNTA / SRRK
Capitalization73.2M3.25B2%
EBITDAN/A-250.12M-
Gain YTD-8.002-20.80138%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A437M-
Total DebtN/A65.1M-
FUNDAMENTALS RATINGS
SRRK: Fundamental Ratings
SRRK
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
75
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SRRK
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLMGX35.39N/A
N/A
Harding Loevner Global Equity Advisor
TILPX28.79N/A
N/A
Nuveen Large Cap Growth Premier
BMISX6.94N/A
N/A
BNY Mellon Income Stock C
FERRX11.46N/A
N/A
First Eagle Global Real Assets R6
IINCX24.42-0.05
-0.20%
Macquarie International Core Eq R6

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with ORMP. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
-0.06%
ORMP - SRRK
42%
Loosely correlated
+3.26%
PLRX - SRRK
41%
Loosely correlated
+1.24%
VTGN - SRRK
40%
Loosely correlated
-0.42%
ONCY - SRRK
39%
Loosely correlated
+8.17%
SNDX - SRRK
39%
Loosely correlated
+2.60%
More